A. Dascalescu

发表

The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.

P. Cianga, A. Dăscălescu, C. Dǎnǎilǎ, 2020, Immunobiology.

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles

Mariana Pavel, P. Cianga, A. Dăscălescu, 2020, Frontiers in Oncology.

Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients

A. Dăscălescu, I. Ivanov, I. Vacarean-Trandafir, 2022, International journal of molecular sciences.

GENOMIC PROFILING BY MULTIPLEX LIGATION - DEPENDENT PROBE AMPLIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

T. Petreuș, G. Grigore, R. Popescu, 2013 .

Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia

H. Einsele, I. Berindan‐Neagoe, Alina-Andreea Zimta, 2019, Frontiers in Immunology.

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma

S. Pașca, B. Petrushev, A. Roman, 2021, Journal of clinical medicine.

RT-PCR ANALYSIS OF E2A-PBX1, TEL-AML1, BCR-ABL AND MLL-AF4 FUSION GENE TRANSCRIPTS IN B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

E. Carasevici, I. Miron, T. Petreuș, 2013 .

Co-expression of the CBFβ-MYH11 and BCR-ABL fusion genes in chronic myeloid leukaemia / Coexistenţa genelor de fuziune CBFβ-MYH11 şi BCR-ABL în leucemia mieloidă cronică

R. Popescu, A. Dăscălescu, C. Dǎnǎilǎ, 2015 .

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response

C. Rusu, P. Cianga, A. Dăscălescu, 2023, Frontiers in Medicine.

ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance

A. Dăscălescu, D. Cojocaru, I. Ivanov, 2019, Molecular Biology Reports.

ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance

A. Dăscălescu, D. Cojocaru, I. Ivanov, 2019, Molecular Biology Reports.

Specific Associations Between Clinical Signs, Immune Cells, Disease Genetic Background and Burden in a Group of Patients with B-Cell Chronic Lymphocytic Leukemia

E. Carasevici, T. Petreuș, G. Grigore, 2014 .

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

I. Berindan‐Neagoe, S. Pașca, B. Petrushev, 2018, Critical reviews in clinical laboratory sciences.

Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study

F. Cavalli, J. Novak, J. Zaucha, 2018, Leukemia & lymphoma.